Search & Analyze

Onesource Specialty Pharma Ltd.

HealthcarePharmaceuticals & Drugs

www.onesourcecdmo.com BSE: 544292NSE: ONESOURCE

₹1,595.50BSE0.65%

16 Sep, 4:01 PM

₹1,595.50

₹18.33K Cr

0.00

3.13

-1.26%

₹1,609.75

₹1,562.20

₹1,924.00

₹1,075.00

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,853.50	36.77	4,44,716.74	0.86	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,199.70	83.50	2,44,223.13	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,823.05	84.11	1,83,453.32	0.79	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,105.00	24.42	1,10,224.17	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,359.75	32.59	1,09,848.55	0.96	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,906.00	94.19	1,02,983.51	0.10	362.07	123.94%	2,026.31	29.10%	18.20
DR.REDDY'S DRREDDY	1,145.25	29.67	95,591.76	0.70	435.60	-69.10%	8,099.80	-5.51%	13.75
Onesource Specialty Pharma Ltd. ONESOURCE	1,595.50	0.00	18,331.03	0.00	25.00	13,539.25%	449.02	37.20%	0.44

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	73.14	292.29	334.05	392.56	425.95	327.27	375.76	290.34	428.22	449.02
Expenses	75.94	228.01	256.23	250.67	243.44	238.79	269.27	273.02	336.30	325.68
	-2.80	64.28	77.82	141.89	182.51	88.48	106.50	17.32	91.92	123.35
	-3.83%	21.99%	23.30%	36.14%	42.85%	27.04%	28.34%	5.97%	21.47%	27.47%
	2.61	-0.51	-1.95	-93.80	2.89	2.40	3.04	-2.47	2.13	-0.50
Interest	20.46	42.05	45.05	45.82	33.41	27.48	33.96	38.23	22.51	30.81
	19.53	68.35	68.28	68.77	68.49	67.80	69.83	69.64	71.83	71.75
	-40.17	-46.62	-37.45	-66.50	83.50	-4.40	5.74	-93.01	-0.29	20.29
	0.00%	88.10%	-12.36%	-3.53%	-18.79%	95.77%	-82.63%	4.64%	1,674.32%	-23.17%
	-40.17	-5.55	-42.08	-68.85	98.50	-0.19	10.49	-88.70	4.60	25.00
	-10.02	-0.51	-10.13	-6.02	8.61	-0.02	0.92	-7.74	0.40	2.18

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	128.18	38.71	171.92	1,444.85	1,434.67
	128.18	38.71	171.92	1,444.85	1,421.59
EXPENDITURE :
Increase/Decrease in Stock				30.10	7.89
Raw Material Consumed		20.41	70.51	404.93	436.76
Power & Fuel Cost	17.79	20.55	20.55	38.32	37.42
Employee Cost	53.36	72.80	79.36	215.26	242.25
Other Manufacturing Expenses	21.27	16.79	17.31	77.17	93.98
General and Administration Expenses	30.19	48.36	64.67	193.66	287.03
Selling and Distribution Expenses	1.50	9.33	0.90	18.32	27.53
Miscellaneous Expenses	8.10	11.16	6.86	3.30	15.95
	132.19	199.40	260.16	981.06	1,148.81
Operating Profit (Excl OI)	-4.01	-160.69	-88.24	463.79	272.78
	3.67	2.69	4.23	20.19	46.46
	-0.34	-158.00	-84.01	483.99	319.24
Interest	46.50	47.55	89.45	166.32	122.19
PBDT	-46.83	-205.54	-173.46	317.66	197.06
	53.07	65.68	76.29	273.88	279.09
Profit Before Taxation & Exceptional Items	-99.91	-271.22	-249.76	43.78	-82.03
Exceptional Income / Expenses		-144.43	-115.94	-110.85	-9.93
	-99.91	-415.65	-365.70	-67.07	-91.96
Provision for Tax	-0.11			-49.79	-18.16
	-99.80	-415.65	-365.70	-17.28	-73.80
Extra items				-0.69	0.00
Consolidated Net Profit	-231.16	-799.83	-391.17	-17.97	-73.80
Profit Balance B/F	-400.51	-631.40	-1,430.75	-1,822.44	-1,843.38
Appropriations	-631.67	-1,431.23	-1,821.92	-1,840.41	-1,917.18
	-76.14	-199.46	-97.55	-1.57	-6.44
Adjusted EPS	-76.14	-199.46	-97.55	-1.57	-6.44

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	3.04	4.01	4.01	11.44	11.46
Share Warrants & Outstandings		5.96	7.92	12.23	6.67
Total Reserves	1,009.44	775.48	383.79	5,856.91	5,813.16
Reserve excluding Revaluation Reserve	1,009.44	775.48	383.79	5,856.91	5,813.16
Revaluation reserve	0.00			0.00
	1,012.48	785.45	395.71	5,880.58	5,831.29
Secured Loans	597.26	284.88	12.10	181.43	563.70
Unsecured Loans		50.00	259.49	37.91
Deferred Tax Assets / Liabilities				155.22	134.85
Other Long Term Liabilities	21.81	21.12	8.32	165.76	219.95
Long Term Provisions	2.11	2.15	2.40	15.79	18.25
Total Non-Current Liabilities	621.19	358.14	282.31	556.10	936.76
Trade Payables	62.54	94.82	81.02	175.51	374.55
Other Current Liabilities	558.95	572.92	535.73	478.09	476.23
Short Term Borrowings	183.86	193.90	9.53	436.01	576.42
Short Term Provisions	3.33	3.58	4.30	23.95	26.81
Total Current Liabilities	808.69	865.22	630.59	1,113.56	1,454.01
Total Liabilities	2,442.36	2,008.81	1,308.61	7,550.24	8,222.05
Gross Block	1,391.52	1,632.59	1,139.17	6,666.17	6,843.82
Less: Accumulated Depreciation	160.37	271.26	276.58	548.64	826.44
Net Block	1,231.15	1,361.33	862.59	6,117.52	6,017.38
Capital Work in Progress	67.76	191.23	42.74	60.37	313.90
Non Current Investments			3.79	6.91	10.22
Long Term Investment	0.00		3.79	6.91	10.22
Long Term Loans & Advances	210.42	82.19	77.03	120.81	226.99
Other Non Current Assets	0.00	2.42	0.80	0.41	0.17
Total Non-Current Assets	1,931.26	1,780.40	1,132.23	6,464.06	6,784.07
Currents Investments		4.50	15.79	8.88	5.46
Inventories	275.48	133.16	11.23	158.06	438.96
Sundry Debtors	23.64	3.82	55.24	416.60	690.22
Cash and Bank	169.74	79.83	60.33	300.90	97.57
Other Current Assets	30.93	1.08	8.11	39.50	28.65
Short Term Loans and Advances	11.31	6.02	25.68	162.24	177.12
Total Current Assets	511.10	228.40	176.38	1,086.18	1,437.98
Net Current Assets (Including Current Investments)	-297.59	-636.81	-454.21	-27.38	-16.03
Total Assets	2,442.36	2,008.81	1,308.61	7,550.24	8,222.05
Contingent Liabilities	150.24	1,144.00	1,137.05	1,164.76	1,287.25
Total Debt	1,154.28	836.69	562.16	771.59	1,276.30
	333.49	194.39	96.71	512.83	508.17
Adjusted Book Value	333.49	194.39	96.71	512.83	508.17

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	-231.16	-799.83	-391.17	-67.76	-91.96
Adjustment	147.42	604.43	288.08	426.80	385.76
Changes In working Capital	-332.15	21.70	-4.13	-419.89	-276.57
Cash Flow after changes in Working Capital	-415.89	-173.70	-107.21	-60.84	17.22
Cash Flow from Operating Activities	-415.89	-162.77	-107.21	-67.85	8.52
Cash Flow from Investing Activities	-691.60	-67.83	510.55	-201.08	-494.98
Cash Flow from Financing Activitie	1,161.96	118.32	-390.54	412.01	359.44
Net Cash Inflow / Outflow	54.47	-112.28	12.79	143.07	-127.02
Opening Cash & Cash Equivalents	67.29	121.76	9.47	22.26	165.36
Cash & Cash Equivalent on Amalgamation / Take over / Merger				0.02
Closing Cash & Cash Equivalent	121.76	9.47	22.26	165.36	38.34

Ratios

Valuation

3.13

55.32

11.88

-4.24

510.17

Profitability

-1.26

0.44

-0.94

19.01

-5.14

Leverage & Liquidity

0.22

0.99

0.25

Returns

0.00

0.18

Shareholding Pattern

Numbers in percentages

Particulars	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	37.77	34.25	29.79	29.77	29.93	30.48	30.48
	29.87	36.44	36.66	37.74	37.92	38.11	42.57
	32.36	29.30	33.55	32.48	32.15	31.41	26.94
	62.23	65.75	70.21	70.23	70.07	69.52	69.52
No. of Shareholders	98,425	82,712	87,760	87,416	84,595	79,460	77,899

Corporate Actions

Showing: All

Date	Type	Details
2026-09-01	AGM
2026-07-20	Board Meeting	Quarterly Results
2026-05-07	Board Meeting	Audited Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Onesource Specialty Pharma Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

A Trisha

Company Secretary & Compliance Officer

—

Arun Kumar

Chairman

—

Debarati Sen